Medico Remedies Limited has informed the Exchange regarding Outcome of Board Meeting held on July 30, 2025.
MEDICO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.5 pts more than Nifty Microcap 250 and 3.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Medico Remedies' board, at its July 30, 2025 meeting, approved several key changes. Mr. Harshit Mehta was re-appointed as Managing Director for three more years starting September 17, 2025, subject to shareholder approval. Mr. Haresh Mehta will continue as Chairman and Whole-Time Director even after turning 70 in August 2025, again pending shareholder nod. Mr. Maheshkumar Darji, currently General Manager – Plant, was appointed as Additional Executive Director, indicating internal promotion. The company's Secretarial Auditor, Mr. Haresh Sanghvi, resigned due to medical reasons, and Ms. Shreya Shah was appointed as the new Secretarial Auditor for a five-year term covering FY 2025-26 to FY 2029-30. Notice for the 31st Annual General Meeting was also approved.
The changes signal continuity in family-led management, with the promoter Mehta family retaining control of key positions, which is neutral to mildly positive for stability but may raise concerns about limited independent board renewal. The auditor change appears procedural and benign.